You just read:

Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients

News provided by

Regeneron Pharmaceuticals, Inc.

May 22, 2017, 17:45 ET